Rational Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Other funds holding IPXL
NTC
FCM
Rational Advisors's IPXL Position: Q1 2017 in Review
Rational Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2017, closing a stake of 3,500 shares — an estimated $46K sold.
Rational Advisors first reported a position in IPXL in Q2 2016 and held it in 3 quarters. The position peaked at $112K in Q2 2016. 178 funds tracked by Wall St. Rank hold IPXL as of Q1 2017.
- Rational Advisors reported no remaining Impax Laboratories, Inc. position as of Q1 2017 after selling out during the quarter.
- Rational Advisors sold 3,500 Impax Laboratories, Inc. shares in Q1 2017, an estimated $46K.
- Rational Advisors first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 3 quarters.
- Rational Advisors's Impax Laboratories, Inc. position peaked at $112K in Q2 2016.
- 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2017.
Based on Rational Advisors's 13F filing for Q1 2017, filed 9 May 2017.